Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 611 for “"Bladder--Cancer"”.
-
Immunotherapy of bladder cancer
… technique. In situ gene transfer to bladder tumors was accomplished via intravesical instillation of plasmid DNA/DOTAP/methyl-beta-cyclodextrin solubilized cholesterol after a single 2h transfection. Moreover, we developed a new model by modifying the bladder cancer cell line MB49 to …
-
METABONOMIC PROFILING OF BLADDER CANCER
Bladder cancer (BC) is the 7th most common cancer worldwide. Although BC is not usually fatal, it is characterized by frequent recurrences that can progress to more invasive disease. The recurrence rates of BC are as high as 50-70%, therefore, life-long close surveillance is needed. This renders BC …
-
Molecular Classification of Bladder Cancer
Decisions in the treatment of bladder cancer today are based on clinical and pathological risk variables such as tumor stage and tumor grade. The importance of these conventional risk variables is well documented since more than 10 years, and they are used routinely in the clinics. Over the last …
-
ECM1 Overexpression in Bladder Cancer
… of genome-wide mRNA expression data from 45 bladder cancer-derived cell lines revealed a Basal/Squamous subgroup exhibiting upregulation of extracellular matrix protein 1 (ECM1). Assessment of ECM1 at the mRNA and protein levels confirmed an ECM1-high subset of cell lines and primary tumours. …
-
Studies of bladder cancer progression
Bladder cancer (BlCa) is the second most common genitourinary cancer, affecting both men and women. Most (70%) cases present at the superficial stage; 20% of these recur with muscle-invasive disease. Major genetic alterations associated with BlCa include: loss/gain in expression or mutations in …
-
Molecular Characterization of Bladder Cancer Subtypes
Bladder cancer is one of the most common malignancies world-wide, and in Sweden approximately 3000 cases are diagnosed annually. Even though bladder cancer is so common there is low public awareness of the disease, and it has historically been less studied compared to other common types of cancer. …
-
Molecular Drivers of Bladder Cancer Motility
Bladder cancer (BC) progression is measured by the degree of tumor cell invasion into the bladder wall and dissemination to distant sites. The study of BC cell motility will both enable development of anti-invasion therapeutics to limit progression of early-stage disease and improve our …
-
Prognostic assessment in superficial bladder cancer
Contains fulltext : mmubn000001_160088445.pdf (Publisher’s version ) (Open Access)
-
Superficial bladder cancer prognosis and management
Contains fulltext : 19207_supeblca.pdf (Publisher’s version ) (Open Access)
-
Molecular prognostic factors in bladder cancer
Contains fulltext : mmubn000001_221553789.pdf (Publisher’s version ) (Open Access)
-
Germline prognostic markers for urinary bladder cancer
The majority of urinary bladder cancer (UBC) cases are diagnosed as non-muscle invasive malignancies, having a favourable prognosis in terms of overall 5-year survival. However, non-muscle invasive bladder cancer (NMIBC) cases show high recurrence and progression rates and inconsistencies within …
-
Smoking and bladder cancer risk and recurrence
… shown to be a major modifiable risk factor for bladder cancer. However, apart from distinguishing between current smokers and former smokers, not many detailed analyses have been performed on lifetime smoking behaviour and bladder cancer risk. Furthermore, smoking cessation after diagnosis of …
-
Predictive biomarkers in muscle-invasive bladder cancer
<p>Organ-confined muscle-invasive bladder cancer (MIBC) is treated with either radical cystectomy (RC) or radiotherapy (RT) and carries survival rates of only 40-60%. There is no clear survival advantage between the two therapies and therefore biomarkers that could aid in the choice of treatment …
-
Clinically relevant MRE11 variants in bladder cancer
… treatment outcomes. Currently, muscle-invasive bladder cancer (MIBC) is treated with cystectomy or radiotherapy/chemoradiation with no clear survival advantage for either option. Identification of predictive biomarkers could facilitate choice between treatments and potentially improve overall …
-
Quality of bladder cancer surgery – improving outcomes
… the time of diagnosis, approximately 75% of all bladder cancers are Non-Muscle Invasive Bladder Cancers (NMIBC) - the standard treatment for these cancers is a Transurethral Resection of the Bladder Tumour (TURBT). Although, the vast majority of these cancers are not life-threatening, they have a …
-
New treatment strategies for superficial bladder cancer.
RU Radboud Universiteit Nijmegen, 09 maart 2006
-
Prognosis and treatment of superficial bladder cancer
Promotores : F. Debruyne, A. van der Meijden en R. Heijbroek
-
Differential Gene Expression Of Muscle-Invasive Bladder Cancer Marker Genes In A Model Of Arsenite And Cadmium Induced Bladder Cancer
Urinary carcinoma is one of the most prevalent cancers across the United States and is among the leading cause of cancer related morbidities. With muscle-invasive urinary carcinoma having only 15% survival at stage T4, diagnostic tools of this type of cancer is necessary. This work sought to …
-
Nuclear receptor co-repressor actions in bladder cancer
… of a range NRs and co-repressors in four bladder cancer cell lines. Nuclear co-repressor 1 (NCoR1) is over-expressed in RT-112 (1.6 fold) and EJ-28 cells (2.6 fold). This correlates with reduced sensitivity to NR ligands in EJ-28 cells. Stable over-expression of NCoR1 in sensitive RT-4 …
Page 1 of 31